非小细胞肺癌根治术后复发转移危险因素研究进展  

Research progress on risk factors of recurrence and metastasis after radical resection of non-small cell lung cancer

作　　者：袁月 李琳[1,2] Yuan Yue;Li Lin(Department of Oncology,Beijing Hospital,National Center of Gerontology,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing 100730,China;Graduate School of Peking Union Medical College,Chinese Academy of Medical Sciences,Beijing 100730,China)

机构地区：[1]北京医院肿瘤内科,国家老年医学中心,中国医学科学院老年医学研究所,北京100730 [2]北京协和医学院研究生院,中国医学科学院,北京100730

出　　处：《中国医学前沿杂志（电子版）》2023年第1期40-45,共6页Chinese Journal of the Frontiers of Medical Science(Electronic Version)

摘　　要：根治性手术是非小细胞肺癌(non-small cell lung cancer,NSCLC)的重要治疗手段之一,目前辅助治疗及预后的判断主要依赖肿瘤原发灶-淋巴结-转移(tumor,node and metastasis,TNM)分期,随着肿瘤检测及治疗手段的不断更新,越来越多的临床、病理、分子、影像预后因素被发现及识别,本文对上述因素的研究进展进行综述,这些因素可能有助于指导区分获益辅助治疗的高危人群,并在未来成为NSCLC根治术后复发转移风险评估的重要部分。Radical surgery is one of the most important treatment methods for non-small cell lung cancer.At present,adjuvant therapy and prognosis mainly rely on the staging of tumor,node and metastasis classification(TNM).With the constant updating of tumor detection and treatment methods,more and more clinical,pathological,molecular and imaging prognostic factors have been found and identified.This paper summarized the research progress of the above factors which may assist to guide the differentiation of high-risk groups who benefit from adjuvant therapy,and become an important part of the risk assessment of recurrence and metastasis after radical resection of non-small cell lung cancer in the future.

关 键 词：非小细胞肺癌 根治术 预后 

分 类 号：R734.2[医药卫生—肿瘤]